Empatica is a Health & Biometric Sensing company founded in 2011 and based in Boston, United States. It has raised $30.9M in total funding, most recently an Undisclosed.
No dated funding rounds on file. This company is privately held and may be raising or operating on undisclosed capital.
No articles ingested yet for Empatica. Once the hourly news pipeline is live, every article the classifier tags as mentioning this company appears here with its one-line AI summary and sentiment.
EmbracePlus is Empatica's medical-grade wrist wearable for continuous physiological monitoring, designed for clinical trials, remote patient monitoring and research. It captures a rich stream of signals — including PPG-derived heart rate and pulse rate variability, electrodermal activity, skin temperature, blood oxygenation, accelerometry and activity and sleep metrics — and feeds them to Empatica's regulated data platform. Used by pharmaceutical sponsors, academic researchers and government programs such as those backed by HHS, USAMRDC and NASA-funded TRISH, EmbracePlus aims to generate trial-grade digital biomarkers from a comfortable, all-day consumer-style device.
Empatica's Health Monitoring Platform is the regulated software and cloud layer that pairs with its EmbracePlus wearable to collect, process and analyze continuous physiological data for clinical and research use. It provides remote-monitoring dashboards, digital-biomarker algorithms, and data-management tooling built to meet the quality and compliance requirements of pharmaceutical trials and medical studies. The platform lets sponsors and clinicians enroll participants, stream sensor data securely, and derive endpoints such as activity, sleep and cardiovascular metrics, turning raw wearable signals into analyzable evidence for drug development and disease management.
3 patents on file, but none with both an extractable figure and an abstract on Google Patents yet.
We don't have a live feed for this company's ATS. Their careers page has every open role.
View all careers ↗